CDEK
← All drugs Report issue

me-344

Small moleculeexperimental

Clinical trial activity

3 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2012 (NCT01544322)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
Mol. weight
348.4 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • me-344
  • me-344
  • me-344
  • me-344

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02806817Early Phase 1 (Phase 1)Jul 1, 2016Fundación CRIS, Universidad Carlos III Madrid
NCT02100007Phase 1/Phase 2 (Phase 2)Apr 1, 2014MEI Pharma, SCRI Development Innovations
NCT01544322Phase 1May 1, 2012MEI Pharma, SCRI Development Innovations
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MEI PharmaFor profit2222012
SCRI Development InnovationsFor profit2022012
Fundación CRISAcademic/Hospital1012016
Universidad Carlos III MadridAcademic/Hospital1112016
4 organizations
Page 1 / 1